Position in CRSP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,057,435
-$443,542 QoQ
Shares Held
85,294
-0.6% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VAN ECK ASSOCIATES CORP holds $332,748,136 across 30 Biotechnology names. CRSP ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
146,116 | $65,246,638 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
62,584 | $48,354,901 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
108,305 | $32,163,335 | |
| 4 | ARGX |
Argenx SE
|
40,397 | $29,499,909 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
54,137 | $17,912,308 | |
| 6 | INSM |
INSMED Inc
|
104,290 | $17,053,500 | |
| 7 | TECH |
BIO-TECHNE Corp
|
317,198 | $16,576,767 | |
| 8 | MRNA |
Moderna, Inc.
|
246,431 | $12,518,694 |
All Filings in CRSP
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,057,435 | 85,294 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,500,977 | 85,831 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,420,967 | 83,644 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,037,606 | 83,010 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,824,829 | 83,010 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,267,273 | 83,010 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $72,631 | 1,546 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $4,308,593 | 79,774 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $4,903,702 | 71,944 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $4,246,845 | 67,841 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $3,305,752 | 72,830 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $4,309,474 | 76,763 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,737,173 | 82,626 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,794,311 | 93,341 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $5,179,444 | 79,257 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $7,672,758 | 126,259 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $7,159,608 | 114,061 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $7,884,605 | 104,046 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $10,784,678 | 96,352 | Shares | Defined | 2021-11-03 | |
| 2021-06-30 | $16,862,300 | 104,159 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $14,510,019 | 119,081 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||